Europe Solid Tumors Drugs Market Report 2016

Publisher Name :
Date: 21-Sep-2016
No. of pages: 126
Inquire Before Buying

Notes:

Sales, means the sales volume of Solid Tumors Drugs

Revenue, means the sales value of Solid Tumors Drugs

This report studies sales (consumption) of Solid Tumors Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Covidien llc (Medtronic)

- Johnson & Johnson MEDICAL

- Bolton Surgical

- Platts & Nisbett

- Frankenman International

- Changzhou Waston

- Jiangsu Qianjing Medical

- Changzhou Anker Medical

- Changzhou Tongchuang Medical

- Jiangsu Reable Medical

- Changzhou Resource Medical

- Jiangsu Kangjin Medical

- CTI BioPharma

- Chugai Pharmaceutical

- NewLink Genetics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Solid Tumors Drugs in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by application, this report focuses on sales, market share and growth rate of Solid Tumors Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

Europe Solid Tumors Drugs Market Report 2016

Table of Contents
Europe Solid Tumors Drugs Market Report 2016
1 Solid Tumors Drugs Overview
1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Classification of Solid Tumors Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Solid Tumors Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Solid Tumors Drugs Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Solid Tumors Drugs (2011-2021)
1.5.1 Europe Solid Tumors Drugs Sales and Growth Rate (2011-2021)
1.5.2 Europe Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
2 Europe Solid Tumors Drugs by Manufacturers, Type and Application
2.1 Europe Solid Tumors Drugs Market Competition by Manufacturers
2.1.1 Europe Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Solid Tumors Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Solid Tumors Drugs (Volume and Value) by Type
2.2.1 Europe Solid Tumors Drugs Sales and Market Share by Type (2011-2016)
2.2.2 Europe Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Solid Tumors Drugs (Volume and Value) by Countries
2.3.1 Europe Solid Tumors Drugs Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Solid Tumors Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Solid Tumors Drugs (Volume) by Application
3 Germany Solid Tumors Drugs (Volume, Value and Sales Price)
3.1 Germany Solid Tumors Drugs Sales and Value (2011-2016)
3.1.1 Germany Solid Tumors Drugs Sales and Growth Rate (2011-2016)
3.1.2 Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
3.1.3 Germany Solid Tumors Drugs Sales Price Trend (2011-2016)
3.2 Germany Solid Tumors Drugs Sales and Market Share by Manufacturers
3.3 Germany Solid Tumors Drugs Sales and Market Share by Type
3.4 Germany Solid Tumors Drugs Sales and Market Share by Application
4 France Solid Tumors Drugs (Volume, Value and Sales Price)
4.1 France Solid Tumors Drugs Sales and Value (2011-2016)
4.1.1 France Solid Tumors Drugs Sales and Growth Rate (2011-2016)
4.1.2 France Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
4.1.4 France Solid Tumors Drugs Sales Price Trend (2011-2016)
4.2 France Solid Tumors Drugs Sales and Market Share by Manufacturers
4.3 France Solid Tumors Drugs Sales and Market Share by Type
4.4 France Solid Tumors Drugs Sales and Market Share by Application
5 UK Solid Tumors Drugs (Volume, Value and Sales Price)
5.1 UK Solid Tumors Drugs Sales and Value (2011-2016)
5.1.1 UK Solid Tumors Drugs Sales and Growth Rate (2011-2016)
5.1.2 UK Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
5.1.5 UK Solid Tumors Drugs Sales Price Trend (2011-2016)
5.2 UK Solid Tumors Drugs Sales and Market Share by Manufacturers
5.3 UK Solid Tumors Drugs Sales and Market Share by Type
5.4 UK Solid Tumors Drugs Sales and Market Share by Application
6 Russia Solid Tumors Drugs (Volume, Value and Sales Price)
6.1 Russia Solid Tumors Drugs Sales and Value (2011-2016)
6.1.1 Russia Solid Tumors Drugs Sales and Growth Rate (2011-2016)
6.1.2 Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
6.1.6 Russia Solid Tumors Drugs Sales Price Trend (2011-2016)
6.2 Russia Solid Tumors Drugs Sales and Market Share by Manufacturers
6.3 Russia Solid Tumors Drugs Sales and Market Share by Type
6.4 Russia Solid Tumors Drugs Sales and Market Share by Application
7 Italy Solid Tumors Drugs (Volume, Value and Sales Price)
7.1 Italy Solid Tumors Drugs Sales and Value (2011-2016)
7.1.1 Italy Solid Tumors Drugs Sales and Growth Rate (2011-2016)
7.1.2 Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
7.1.7 Italy Solid Tumors Drugs Sales Price Trend (2011-2016)
7.2 Italy Solid Tumors Drugs Sales and Market Share by Manufacturers
7.3 Italy Solid Tumors Drugs Sales and Market Share by Type
7.4 Italy Solid Tumors Drugs Sales and Market Share by Application
8 Spain Solid Tumors Drugs (Volume, Value and Sales Price)
8.1 Spain Solid Tumors Drugs Sales and Value (2011-2016)
8.1.1 Spain Solid Tumors Drugs Sales and Growth Rate (2011-2016)
8.1.2 Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
8.1.8 Spain Solid Tumors Drugs Sales Price Trend (2011-2016)
8.2 Spain Solid Tumors Drugs Sales and Market Share by Manufacturers
8.3 Spain Solid Tumors Drugs Sales and Market Share by Type
8.4 Spain Solid Tumors Drugs Sales and Market Share by Application
9 Benelux Solid Tumors Drugs (Volume, Value and Sales Price)
9.1 Benelux Solid Tumors Drugs Sales and Value (2011-2016)
9.1.1 Benelux Solid Tumors Drugs Sales and Growth Rate (2011-2016)
9.1.2 Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Solid Tumors Drugs Sales Price Trend (2011-2016)
9.2 Benelux Solid Tumors Drugs Sales and Market Share by Manufacturers
9.3 Benelux Solid Tumors Drugs Sales and Market Share by Type
9.4 Benelux Solid Tumors Drugs Sales and Market Share by Application
10 Europe Solid Tumors Drugs Manufacturers Analysis
10.1 Covidien llc (Medtronic)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Solid Tumors Drugs Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Covidien llc (Medtronic) Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Johnson & Johnson MEDICAL
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Solid Tumors Drugs Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Johnson & Johnson MEDICAL Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Bolton Surgical
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Solid Tumors Drugs Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Bolton Surgical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Platts & Nisbett
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Solid Tumors Drugs Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Platts & Nisbett Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Frankenman International
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Solid Tumors Drugs Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Frankenman International Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Changzhou Waston
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Solid Tumors Drugs Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Changzhou Waston Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Jiangsu Qianjing Medical
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Solid Tumors Drugs Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Jiangsu Qianjing Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Changzhou Anker Medical
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Solid Tumors Drugs Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Changzhou Anker Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Changzhou Tongchuang Medical
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Solid Tumors Drugs Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Changzhou Tongchuang Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Jiangsu Reable Medical
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Solid Tumors Drugs Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Jiangsu Reable Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
10.11 Changzhou Resource Medical
10.12 Jiangsu Kangjin Medical
10.13 CTI BioPharma
10.14 Chugai Pharmaceutical
10.15 NewLink Genetics
11 Solid Tumors Drugs Manufacturing Cost Analysis
11.1 Solid Tumors Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Solid Tumors Drugs
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Solid Tumors Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Solid Tumors Drugs Market Forecast (2016-2021)
14.1 Germany Solid Tumors Drugs Sales Forecast (2016-2021)
14.2 France Solid Tumors Drugs Sales Forecast (2016-2021)
14.3 UK Solid Tumors Drugs Sales Forecast (2016-2021)
14.4 Russia Solid Tumors Drugs Sales Forecast (2016-2021)
14.5 Italy Solid Tumors Drugs Sales Forecast (2016-2021)
14.6 Spain Solid Tumors Drugs Sales Forecast (2016-2021)
14.7 Benelux Solid Tumors Drugs Sales Forecast (2016-2021)
14.8 Europe Solid Tumors Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Solid Tumors Drugs Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Solid Tumors Drugs
Table Classification of Solid Tumors Drugs
Figure Europe Sales Market Share of Solid Tumors Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Solid Tumors Drugs
Figure Europe Sales Market Share of Solid Tumors Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure France Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure UK Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Solid Tumors Drugs Sales and Growth Rate (2011-2021)
Figure Europe Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Table Europe Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers
Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers
Table Europe Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 Europe Solid Tumors Drugs Revenue Share by Manufacturers
Table Europe Solid Tumors Drugs Sales and Market Share by Type (2011-2016)
Table Europe Solid Tumors Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Solid Tumors Drugs by Type (2011-2016)
Figure Europe Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Solid Tumors Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Solid Tumors Drugs by Type (2011-2016)
Figure Europe Solid Tumors Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Solid Tumors Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Solid Tumors Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Solid Tumors Drugs by Countries (2011-2016)
Table Europe Solid Tumors Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Solid Tumors Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Solid Tumors Drugs by Countries (2011-2016)
Table Europe Solid Tumors Drugs Sales and Market Share by Application (2011-2016)
Table Europe Solid Tumors Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Solid Tumors Drugs by Application (2011-2016)
Figure Germany Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure Germany Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Solid Tumors Drugs Sales Price Trend (2011-2016)
Table Germany Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Solid Tumors Drugs Sales by Type (2015 and 2016)
Table Germany Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table Germany Solid Tumors Drugs Sales by Application (2015 and 2016)
Table Germany Solid Tumors Drugs Market Share by Application (2015 and 2016)
Figure France Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure France Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure France Solid Tumors Drugs Sales Price Trend (2011-2016)
Table France Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table France Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table France Solid Tumors Drugs Sales by Type (2015 and 2016)
Table France Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table France Solid Tumors Drugs Sales by Application (2015 and 2016)
Table France Solid Tumors Drugs Market Share by Application (2015 and 2016)
Figure UK Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure UK Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure UK Solid Tumors Drugs Sales Price Trend (2011-2016)
Table UK Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table UK Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Solid Tumors Drugs Sales by Type (2015 and 2016)
Table UK Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table UK Solid Tumors Drugs Sales by Application (2015 and 2016)
Table UK Solid Tumors Drugs Market Share by Application (2015 and 2016)
Figure Russia Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure Russia Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Solid Tumors Drugs Sales Price Trend (2011-2016)
Table Russia Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Solid Tumors Drugs Sales by Type (2015 and 2016)
Table Russia Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table Russia Solid Tumors Drugs Sales by Application (2015 and 2016)
Table Russia Solid Tumors Drugs Market Share by Application (2015 and 2016)
Figure Italy Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure Italy Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Solid Tumors Drugs Sales Price Trend (2011-2016)
Table Italy Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Solid Tumors Drugs Sales by Type (2015 and 2016)
Table Italy Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table Italy Solid Tumors Drugs Sales by Application (2015 and 2016)
Table Italy Solid Tumors Drugs Market Share by Application (2015 and 2016)
Figure Spain Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure Spain Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Solid Tumors Drugs Sales Price Trend (2011-2016)
Table Spain Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Solid Tumors Drugs Sales by Type (2015 and 2016)
Table Spain Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table Spain Solid Tumors Drugs Sales by Application (2015 and 2016)
Table Spain Solid Tumors Drugs Market Share by Application (2015 and 2016)
Figure Benelux Solid Tumors Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Solid Tumors Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Solid Tumors Drugs Sales Price Trend (2011-2016)
Table Benelux Solid Tumors Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Solid Tumors Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Solid Tumors Drugs Sales by Type (2015 and 2016)
Table Benelux Solid Tumors Drugs Market Share by Type (2015 and 2016)
Table Benelux Solid Tumors Drugs Sales by Application (2015 and 2016)
Table Benelux Solid Tumors Drugs Market Share by Application (2015 and 2016)
Table Solid Tumors Drugs Basic Information List
Table Covidien llc (Medtronic) Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Covidien llc (Medtronic) Solid Tumors Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson MEDICAL Basic Information List
Table Johnson & Johnson MEDICAL Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson MEDICAL Solid Tumors Drugs Sales Market Share (2011-2016)
Table Bolton Surgical Basic Information List
Table Bolton Surgical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bolton Surgical Solid Tumors Drugs Sales Market Share (2011-2016)
Table Platts & Nisbett Basic Information List
Table Platts & Nisbett Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Platts & Nisbett Solid Tumors Drugs Sales Market Share (2011-2016)
Table Frankenman International Basic Information List
Table Frankenman International Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Frankenman International Solid Tumors Drugs Sales Market Share (2011-2016)
Table Changzhou Waston Basic Information List
Table Changzhou Waston Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Waston Solid Tumors Drugs Sales Market Share (2011-2016)
Table Jiangsu Qianjing Medical Basic Information List
Table Jiangsu Qianjing Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Qianjing Medical Solid Tumors Drugs Sales Market Share (2011-2016)
Table Changzhou Anker Medical Basic Information List
Table Changzhou Anker Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Anker Medical Solid Tumors Drugs Sales Market Share (2011-2016)
Table Changzhou Tongchuang Medical Basic Information List
Table Changzhou Tongchuang Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Tongchuang Medical Solid Tumors Drugs Sales Market Share (2011-2016)
Table Jiangsu Reable Medical Basic Information List
Table Jiangsu Reable Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Reable Medical Solid Tumors Drugs Sales Market Share (2011-2016)
Table Changzhou Resource Medical Basic Information List
Table Changzhou Resource Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changzhou Resource Medical Solid Tumors Drugs Sales Market Share (2011-2016)
Table Jiangsu Kangjin Medical Basic Information List
Table Jiangsu Kangjin Medical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Kangjin Medical Solid Tumors Drugs Sales Market Share (2011-2016)
Table CTI BioPharma Basic Information List
Table CTI BioPharma Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CTI BioPharma Solid Tumors Drugs Sales Market Share (2011-2016)
Table Chugai Pharmaceutical Basic Information List
Table Chugai Pharmaceutical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chugai Pharmaceutical Solid Tumors Drugs Sales Market Share (2011-2016)
Table NewLink Genetics Basic Information List
Table NewLink Genetics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NewLink Genetics Solid Tumors Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure Germany Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Solid Tumors Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Solid Tumors Drugs Sales Forecast by Type (2016-2021)
Table Europe Solid Tumors Drugs Sales Forecast by Application (2016-2021)
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • EMEA (Europe, Middle East and Africa) Non-Gelatin Empty Capsules Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the EMEA Non-Gelatin Empty Capsules market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Non-Gelatin Empty Capsules for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy a......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 127
    In this report, the global Foot and Mouth Disease (FMD) Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Foot and Mouth Disease (FMD) Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America......
  • Asia-Pacific Succinylated Keyhole Limpet Hemocyanin Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 100
    In this report, the Asia-Pacific Succinylated Keyhole Limpet Hemocyanin market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Succinylated Keyhole Limpet Hemocyanin for these regions, from 2012 to 2022 (forecast), including - China......
  • Asia-Pacific Sulbactam Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the Asia-Pacific Sulbactam market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Sulbactam for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan ......
  • Global Tourniquet Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Tourniquet market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Tourniquet in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan ......
  • 2017-2022 China Liquid Biopsy Products Market Report (Status and Outlook)
    Published: 24-May-2017        Price: US 3360 Onwards        Pages: 119
    "This report will be delivered in 2-3 business days after the order is placed." The Liquid Biopsy Products market size will be XX million (USD) in 2022 in China, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022. In China market, the top players include - RainDanceTechnologies - Biocartis - Qiagen - Guardant Health - MDxHealth - Pathway Genomics - NeoGe......
  • EMEA (Europe, Middle East and Africa) Peritoneal Dialysis Solution Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the EMEA Peritoneal Dialysis Solution market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K L), revenue (Million USD), market share and growth rate of Peritoneal Dialysis Solution for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Ital......
  • Asia-Pacific Tramadol Hcl Market Report 2017
    Published: 24-May-2017        Price: US 4000 Onwards        Pages: 110
    In this report, the Asia-Pacific Tramadol Hcl market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Tramadol Hcl for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea - Taiwan......
  • Global Solid Organ Transplant Immunosuppressant Market Research Report 2017
    Published: 24-May-2017        Price: US 2900 Onwards        Pages: 109
    In this report, the global Solid Organ Transplant Immunosuppressant market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Solid Organ Transplant Immunosuppressant in these regions, from 2012 to 2022 (forecast), covering - North A......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs